Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amlitelimab for Eczema
Recruiting1 awardPhase 3
Ajax, Ontario
This trial is a Phase 3 study for treating moderate-to-severe atopic dermatitis in participants aged 12 years and older. The study aims to see if participants who responded well to aml
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.